title: Localization of trapping of 6-[(18)F]fluoro-L-m-tyrosine, an aromatic L-amino acid decarboxylase tracer for PET.
abstract: The purpose of this study was to address four major questions regarding 6-FMT, a noncatecholic PET tracer for AAAD: 1) Where is the specific uptake of 6-FMT? 2) Why does it accumulate where and to the degree that it does? 3) How does its uptake differ from that of fluoroDOPA globally? and 4) Does its regional uptake differ significantly from that of fluoroDOPA? High-resolution PET scans were obtained in three rhesus monkeys using 6-FMT and in two of them using fluoroDOPA. Anatomic distribution was analyzed visually and quantitative uptake of 6-FMT was compared with published regional decarboxylase activity and monoamine neurotransmitter concentrations. In addition to high uptake in the dopamine-rich striatal nuclei, there was specific uptake of 6-FMT in brain regions which have little dopaminergic innervation but which have other amines in significant concentration. 6-FMT uptake correlated best with regional AAAD activity (r = 0.97). It correlated slightly less well with the sum of catecholamine and indolamine neurotransmitter concentrations, but does not correlate with dopamine concentration. The uptake of 6-FMT is greater than that of fluoroDOPA, with only slight differences in their regional distributions. Radiolabeled analogs of DOPA are often implicitly or explicitly regarded as tracers for presynaptic dopaminergic function. However, localization of these tracers more broadly includes many regions with relatively high concentrations of norepinephrine and serotonin. This may be especially important in diseases or experimental states in which dopaminergic neurons are selectively reduced, and may allow for the study of nondopaminergic neuronal systems in vivo with this tracer.
authors.affiliation: Department of Radiology, University of Wisconsin-Madison, USA. wbrown@facstaff.wisc.edu
authors.forename: W D
authors.initials: WD
authors.lastname: Brown
authors.forename: O T
authors.initials: OT
authors.lastname: DeJesus
authors.forename: R W
authors.initials: RW
authors.lastname: Pyzalski
authors.forename: L
authors.initials: L
authors.lastname: Malischke
authors.forename: A D
authors.initials: AD
authors.lastname: Roberts
authors.forename: S E
authors.initials: SE
authors.lastname: Shelton
authors.forename: H
authors.initials: H
authors.lastname: Uno
authors.forename: W D
authors.initials: WD
authors.lastname: Houser
authors.forename: R J
authors.initials: RJ
authors.lastname: Nickles
authors.forename: J E
authors.initials: JE
authors.lastname: Holden
mesh_terms: D000818:Animals; D001921:Brain / Q000000981:diagnostic imaging / Q000378:metabolism*; D004295:Dihydroxyphenylalanine / Q000031:analogs & derivatives / Q000493:pharmacokinetics; D005462:Fluorine Radioisotopes / Q000493:pharmacokinetics*; D008253:Macaca mulatta; D009928:Organ Specificity; D013997:Time Factors; D014055:Tomography, Emission-Computed; D014443:Tyrosine / Q000031:analogs & derivatives* / Q000493:pharmacokinetics
chemical_list: D005462:Fluorine Radioisotopes; C080704:6-fluoro-3-tyrosine; C043437:fluorodopa F 18; D014443:Tyrosine; D004295:Dihydroxyphenylalanine